Weight Loss Injection Programmes at MDC

Mounjaro (tirzepatide) can be an effective treatment for weight loss when prescribed and monitored by a healthcare professional. The medication works by mimicking hormones that regulate appetite and blood sugar, which can help people lose weight and improve metabolic health.

However, like all medications, Mounjaro may cause side effects. Common side effects include nausea, vomiting, diarrhoea, and reduced appetite. In rare cases, it may affect the pancreas, gallbladder, or thyroid. For this reason, it is important that treatment is started and monitored under medical supervision.

Blood tests are not always mandatory, but they are strongly recommended before and during treatment. Doctors often check key markers such as:

• Liver and kidney function
• Blood glucose and HbA1c
• Cholesterol levels
• Thyroid function

These tests help ensure the medication is safe for the patient and allow clinicians to monitor how the body responds to treatment. Monitoring is particularly important for patients with existing health conditions.

Mounjaro should only be taken under the supervision of a qualified healthcare professional. In the UK, it is a prescription-only medication. A doctor or authorised prescriber must assess whether the treatment is appropriate and safe for the patient.

Some patients obtain prescriptions through online pharmacies. However, even in those cases, medical monitoring and regular health checks are strongly recommended.

A baseline blood test is usually recommended before starting treatment. After treatment begins, doctors may suggest follow-up testing depending on the patient's health and risk factors.

A common monitoring approach includes: baseline blood tests before treatment, a follow-up test after 6–12 weeks, and additional monitoring every few months if treatment continues.

Mounjaro (tirzepatide) is not primarily a fertility treatment. However, weight loss and improved metabolic health can indirectly improve fertility in some individuals.

Excess weight and insulin resistance can affect hormones involved in reproduction. When patients lose weight with medications such as Mounjaro, hormone balance may improve. This may support ovulation in women and potentially improve sperm quality in men.

However, research on the direct effects of Mounjaro on fertility is still limited. Patients who are planning pregnancy should discuss treatment with a doctor. In many cases, weight-loss injections are stopped before trying to conceive.

Medical supervision and appropriate testing can help ensure treatment remains safe.

Hair loss has been reported by some patients using GLP-1 weight loss medications, including Mounjaro. However, the medication itself is not usually the direct cause.

Hair loss during weight-loss treatment is often related to rapid weight reduction, nutritional changes, or temporary stress on the body. This type of hair shedding is sometimes called telogen effluvium and is usually temporary.

Ensuring adequate nutrition and monitoring key nutrients may help reduce the risk. Doctors may check levels of iron, vitamin B12, vitamin D, and thyroid function if hair loss occurs.

Most patients experience hair regrowth once the body adapts to weight changes and nutritional balance improves.

Many patients notice a reduction in appetite within the first few weeks of starting Mounjaro. Weight loss usually becomes more noticeable after several weeks as the medication helps regulate hunger and blood sugar levels.

Clinical studies have shown that significant weight loss can occur over several months when the medication is used alongside lifestyle changes such as diet and exercise.

The response can vary between individuals. Regular monitoring helps ensure the treatment is effective and well tolerated.

The most commonly reported side effects are related to the digestive system. These may include:

• nausea
• vomiting
• diarrhoea
• constipation
• reduced appetite
• stomach discomfort

These symptoms often occur during the early stages of treatment or when the dose increases. In many patients, symptoms improve as the body adjusts.

Patients should speak with a healthcare professional if side effects become severe or persistent.

Mounjaro may not be suitable for everyone. It should not be used by individuals with certain medical conditions unless advised by a doctor.

Patients should speak with a healthcare professional before starting treatment if they:

• have a history of pancreatitis
• have severe gastrointestinal disease
• have a personal or family history of certain thyroid cancers
• are pregnant or planning pregnancy

A medical assessment and baseline blood tests can help determine whether the treatment is appropriate and safe.